HOXA13 and Syndactyly type 2: HOXD13/HOXA13/RUNX2 condensates with expanded polyalanine mutation fail to recruit coactivators and disrupt the formation of transcriptionally active TADs, causing synpolydactyly, hand-foot genital syndrome, or cleidocranial dysplasia.